Eye drops could stop a rare cause of blindness
NCT ID NCT02987686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested whether infliximab, a drug usually given through a vein, can be safely used as eye drops for sterile corneal melt. This condition causes the clear front part of the eye to thin, which can lead to blindness. Seven adults with this condition received the eye drops for 4 weeks to check for side effects and see if the treatment helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STERILE CORNEAL MELT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de l'Université de Montréal
Montreal, Quebec, H2X3E4, Canada